Literature DB >> 29179990

Snakebite by Micrurus averyi (Schmidt, 1939) in the Brazilian Amazon basin: Case report.

Iran Mendonça da Silva1, Jorge Contreras Bernal1, Pedro Ferreira Gonçalves Bisneto2, Antônio Magela Tavares2, Valéria Mourão de Moura1, Claudio S Monteiro-Junior1, Rima Raad1, Paulo Sergio Bernarde3, Jacqueline de Almeida Gonçalves Sachett4, Wuelton Marcelo Monteiro1.   

Abstract

Micrurus snakes, commonly known as coral snakes, are responsible for 0.4% of the snakebites envenomings in Brazil. In this report, we describe a case of envenoming by Micrurus averyi, the black-headed coral snake, recorded in the western Brazilian Amazon. To the best of our knowledge, this is the first published case perpetrated by this species. The major complaint of the patient was an intense local pain and paresthesia. Examination of the bite site revealed edema extending from the left foot up the left leg that was accompanied by erythema involving the foot and distal third of the leg. Systemic signs at admission included nausea and drooling. The patient was treated with 100 mL of coral snake antivenom and intravenous analgesics (dipyrone) and was discharged 48 h post-admission with no complaints. The patient showed more intense local edema than that generally described in several other cases of Micrurus bites in Brazil.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coral snake; Edema; Micrurus; Snakebite

Mesh:

Substances:

Year:  2017        PMID: 29179990     DOI: 10.1016/j.toxicon.2017.11.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  1 in total

1.  A Combined Strategy to Improve the Development of a Coral Antivenom Against Micrurus spp.

Authors:  Karen Larissa Pereira de Castro; Letícia Lopes-de-Souza; Daysiane de Oliveira; Ricardo Andrez Machado-de-Ávila; Ana Luiza Bittencourt Paiva; Cláudio F de Freitas; Paulo Lee Ho; Carlos Chávez-Olórtegui; Clara Guerra-Duarte
Journal:  Front Immunol       Date:  2019-10-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.